Founded in April 2016 by experienced radionuclides researchers, the company specializes in research, manufacturing, and sales of medical isotopes and products. They offer services for malignant tumor diagnosis and treatment, as well as radionuclides medicine technology support and consulting. With over 80 employees, including more than 60 R&D specialists, the company is considered the most innovative technology enterprise in the radiopharmaceutical industry in China.